Doe v. CUTTER BIOLOGICAL, a DIV. OF MILES INC.

844 F. Supp. 602, 1994 WL 58362, 1994 U.S. Dist. LEXIS 2131
District Court, D. Idaho·Decided February 24, 1994·No. Civ. 92-0434-S-HLR·Published·Cited by 8 cases

Opinion

AMENDED ORDER ON MOTIONS FOR SUMMARY JUDGMENT AND PLAINTIFF’S MOTIONS TO AMEND

RYAN, Senior District Judge.

I. FACTS AND PROCEDURE

Plaintiff John Doe is a hemophiliac. Because of his condition, John Doe received a clotting agent known as Factor VIII which facilitates the clotting of blood in hemophiliacs.

In December of 1991, John Doe tested positive for the HIV virus. On October 30, 1992, John Doe commenced this federal action naming those providers of the Factor VIII products which were administered to him by the Pocatello Regional Medical Center between 1979 and 1985. 1 Originally, the named defendants included: Cutter Biological, a division of Miles Inc.; Miles Laboratories, Inc.; Armour Pharmaceutical Corporation (Armour); and Alpha Therapeutic Corporation. At this juncture, however, Alpha Therapeutic Corporation has been dismissed with prejudice, 2 and therefore, Miles Inc., 3 and Armour represent the two remaining defendants.

The following motions are currently pending before the court: (1) [Plaintiffs] Motion for Partial Summary Judgment and Motion in Limine, filed August 3, 1993; (2) Defendant Miles’ Motion for Summary Judgment, filed October 15, 1993; (3) Armour’s Motion for Summary Judgment, filed October 15, 1993; (4) plaintiffs Motion to File Second Amended Complaint and Demand for Jury Trial, filed October 1, 1993; and (5) [Plaintiffs] Motion in Limine for Ruling Regarding Pleading of Strict Liability or Motion for Leave to Amend Complaint, filed November 15, 1993.

On February 17, 1994, a hearing on all pending motions was conducted by the court. At the beginning of the hearing, the court advised counsel that, based on the dictates of the United States Supreme Court, the Ninth Circuit Court of Appeals, and Idaho Appellate Rule 12.1, an Order of Certification, setting forth questions regarding the issue of causation as well as the interpretation of Idaho’s blood shield statute, would be sent to the Idaho Supreme Court. See Ord. of Certification, filed Feb. 17, 1994. The court *604 advised further that, pending such certification, [Plaintiffs] Motion for Partial Summary Judgment and Motion in Limine; Defendants’ motions for summary judgment on the issue of causation; and [Plaintiffs] Motion in Limine for Ruling Regarding Pleading of Strict Liability or Motion for Leave to Amend Complaint would each be denied without prejudice.

Based on the foregoing, 4 together with an Order on Certain Non-Dispositive Motions filed February 11, 1994, the court requested counsel to limit their oral arguments to the two remaining matters requiring resolution: (1) defendants’ motions for summary judgment based on the statute of limitations; and (2) plaintiffs Motion to File Second Amended Complaint and Demand for Jury Trial to add a claim for punitive damages.

Now, having fully considered the record herein, as well as the oral arguments of counsel, and for the reasons contained in the analysis set forth below, defendants’ motions for summary judgment based on the statute of limitations shall be denied; and plaintiffs Motion to File Second Amended Complaint and Demand for Jury Trial to add a claim for punitive damages shall be granted.

II. ANALYSIS OF MOTIONS ARGUED AT FEBRUARY 17, 1994, HEARING

A. Defendants’ Motions for Summary Judgment Re: Statute of Limitations

1.Positions taken by the parties.

Both Miles and Armour filed motions for summary judgment based on the two-year statute of limitations set forth in Idaho Code § 5-219(4). In particular, Miles moved for summary judgment “on the grounds that plaintiffs injury was objectively ascertainable in 1985 and his action is, therefore, barred by the applicable statute of limitations.” Mem. of Points & Authorities in Supp. of Miles’ Mot. for Summ.J., filed Oct. 15, 1993, at 2. And, Armour moved for summary judgment on the grounds that:

1. The statute of limitations starts with the onset of “objectively ascertainable” injury.
2. The “objective medical proof’ in the instant case shows that plaintiff[] did not file [his] action within two years of the time damages were “objectively ascertainable.”
3. The damage to plaintiff[] was “objectively ascertainable” if [John Doe would have been] tested for HIV as recommended by the physicians and nurses treating him.

Armour’s Mem.Supp. of Mot. for Summ.J., filed Oct. 15, 1993, Contents at 2.

More specifically, defendants rely upon the following facts in support of their positions.

Miles notes that John Doe “experienced symptoms consistent with HIV infection in 1981, 1983, and 1985.” Mem. of Points & Authorities in Supp. of Miles’ Mot. for Summ.J., filed Oct. 15, 1993, at 7. Miles provides the following chronology in support of the statute of limitations argument.

—In June of 1981, John Doe experienced “weakness of undiagnosed origin” and “was also found to be positive on a ‘mono spot’ test, a test for mononucleosis.” Id. at 8.

• — -In May 1983, John Doe suffered from a “two-week history of swollen glands, including axillary nodes (lymph nodes in the arm pits), as well as inguinal nodes (lymph nodes in the groin).” Id.

—In August 1983, John Doe’s medical records reflect that Dr. Brydon discussed AIDS with him. Id.

—In January 1985, John Doe suffered from herpes zoster, also known as “shingles.” Id.

—In July 1985, Dr. Mickelson treated John Doe for orthopedic problems and discussed AIDS with John Doe and his mother. Id.

—In 1985, Dr. Boe urged John Doe’s mother to have her son tested for HIV infection. Id.

*605 —In 1988, Robina Ingram, a nurse from the Oregon Health Sciences University Hemophilia Outreach Program, met with John Doe’s mother and urged her to have him tested for AIDS. Id. at 16.

• — In 1991, John Doe tested positive for HIV infection. Id. at 8.

Miles points out that heat-treated factor concentrate is believed to inactivate HIV and no infection with heat-treated factor concentrate has been established. Id. at 14. Plaintiffs treating physician, Dr. Roger Boe, estimates that because plaintiff was using non-heat-treated Factor VIII products until 1984, “there was a 70-80% chance that John Doe was infected with HIV prior to August 1984.” Id. at 14.

Ultimately, Miles concludes its opening brief by stating:

Plaintiff, in all likelihood, became infected with HIV prior to August 1984.

Free access — add to your briefcase to read the full text and ask questions with AI

Doe v. CUTTER BIOLOGICAL, a DIV. OF MILES INC., 844 F. Supp. 602, 1994 WL 58362, 1994 U.S. Dist. LEXIS 2131 (D. Idaho 1994).

844 F. Supp. 602 (Doe v. CUTTER BIOLOGICAL, a DIV. OF MILES INC.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related